Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Mar 03, 2023 |
signed chap.76 delivered to governor |
Jan 18, 2023 |
returned to senate passed assembly ordered to third reading rules cal.15 substituted for a996 |
Jan 18, 2023 |
substituted by s821 |
Jan 17, 2023 |
ordered to third reading rules cal.15 rules report cal.15 reported reported referred to rules |
Jan 12, 2023 |
referred to health |
Assembly Bill A996
Signed By Governor2023-2024 Legislative Session
Sponsored By
GONZALEZ-ROJAS
Current Bill Status Via S821 - Signed by Governor
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
2023-A996 (ACTIVE) - Details
- See Senate Version of this Bill:
- S821
- Law Section:
- Tax Law
- Laws Affected:
- Amd §498, Tax L (as proposed in S.7378-A & A.8339-A)
2023-A996 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 996 2023-2024 Regular Sessions I N A S S E M B L Y January 12, 2023 ___________ Introduced by M. of A. GONZALEZ-ROJAS -- read once and referred to the Committee on Health AN ACT to amend the tax law, in relation to availability of certain reports detailing sales of opioids in this state THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision (g) of section 498 of the tax law, as amended by a chapter of the laws of 2022 amending the tax law relating to requiring the department of health to publish certain reports on depart- ment's website detailing sales of opioids sold in the state, as proposed in legislative bills numbers S. 7378-A and A. 8339-A, is amended to read as follows: (g) Each registrant shall provide a report to the department of health detailing all opioids sold by such registrant in the state of New York. Such report shall include: (i) the registrant's name, address, phone number, federal Drug Enforcement Agency (DEA) registration number, education department registration number, and controlled substance license number issued by the department of health, if applicable; (ii) the name, address and DEA registration number of the entity to whom the opioid was sold; (iii) the date of the sale of the opioid; (iv) the gross receipt total, in dollars, for each opioid sold; (v) the name and National Drug Code of the opioid sold; (vi) the number of containers and the strength and metric quantity of controlled substance in each container of the opioid sold; (vii) the total number of morphine milligram equivalents sold; and (viii) any other elements as deemed necessary by the commissioner of health. Such information shall be reported [and published] annually in such form as defined by the commissioner of health and shall not be subject EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03968-01-3
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.